ferluisgo

https://drfernandogomezaguado.com/Cartinew: A Breakthrough Orthopaedic Solution Developed by Venezuelan Surgeon Dr. Fernando Luis Gómez Aguado “Cartinew: A Successful Solution for Orthopaedic Patients Created by a Venezuelan Physician” Venezuelans continue to make impressive strides on the global medical stage. One outstanding example is Dr. Fernando Luis Gómez Aguado, an orthopaedic surgeon / traumatologist born in Anzoátegui, Venezuela, whose pioneering work with Cartinew is revolutionising joint-health treatments. With more than 25 years of distinguished professional experience, Dr. Gómez Aguado has been recognised by the Fundación Mara de Oro de Venezuela Internacional as one of the “Best of the Best” – a select list of top-Venezuelan professionals with international projection. He graduated from the Universidad de Oriente (UDO) in Anzoátegui, completed his surgical residency at Hospital Domingo Guzmán Lander (Barcelona, Anzoátegui), followed by postgraduate training in Traumatology at the Hospital Central de Valencia, and further fellowship training in the United States focussed on complex shoulder and knee surgery. He has served at major Venezuelan hospitals (e.g., Dr. Luis Razetti Hospital, Hospital Las Garzas, Hospital Central de Valencia), held academic positions in universities, and is a member of numerous professional societies including the Sociedad Venezolana de Cirugía Ortopédica, the Sociedad Latinoamericana de Hombro y Codo, and the American Society for Arthroscopy of Knee and Shoulder. --- Why Cartinew Matters: The Need & Innovation Joint degeneration (arthritis, osteoarthritis, cartilage wear) remains one of the leading causes of chronic pain, reduced mobility and diminished quality of life worldwide. Traditional treatments often address symptoms (pain, inflammation) but do little to regenerate cartilage or reverse joint damage. Cartinew was developed to fill this gap. It is described as a regenerative‐oriented solution for joint health—promoting cartilage repair, improving mobility, alleviating pain, and offering an alternative or adjunct to surgery or long-term pharmaceuticals. According to the product site, Cartinew is available in three presentation forms: capsules, roll-on and spray, making it versatile for “whole-body joint health” or topical/localised relief. The formulation is claimed to include elements such as hyaluronic acid, active peptides, stem-cell technologies, collagen, telomere-targeted ingredients and MK-7 (menaquinone-7) as part of the “next-generation joint health” paradigm. --- Key Benefits & Features According to available material, Cartinew offers the following benefits: Promotes cartilage regeneration, helping to repair damaged joint surfaces. Improves joint mobility and range of motion, supporting an active lifestyle even in presence of degenerative changes. Provides pain relief and anti-inflammatory effects, targeting arthrosis, chronic joint pain and functional stiffness. Helps slow the progression of osteoarthritis, potentially delaying or avoiding joint replacement surgery. Applies not only internally (capsules) but externally (roll-on, spray) for localised joint/muscle-soft tissue support. Incorporates advanced ingredients: Hyaluronic acid: naturally present in synovial fluid, essential for lubrication and shock absorption. Collagen: supports bone, tendon and ligament strength, contributing to joint stability. Active peptides: for tissue repair, inflammation modulation. Stem-cell components (in some formulations): for cartilage repair/regeneration. Telomere-supportive agents: addressing cell ageing and regeneration capacity. MK-7 (menaquinone-7): a vitamin-K2 form claimed to support bone & cartilage health in arthritic conditions. --- Clinical Context & Usage Markets Cartinew is available in multiple markets: USA, Costa Rica, Mexico, Venezuela (as you previously specified you’d like highlighted). The product is positioned for both athletes and non-athletes experiencing joint degeneration, pain or loss of mobility. Dr. Gómez Aguado reports that over 5,000 patients have already benefited from the therapy, emphasising real-world impact and clinical relevance. --- Patient Testimonials & Real-World Impact Although individual detailed case reports are not widely published, the Cartinew website features “Patients relieved” and user-feedback sections pointing to meaningful improvement in joint pain, mobility and quality of life. For example, patients with chronic knee pain and early-stage osteoarthritis reported improved flexibility, reduced use of pain medications, and return to sports / active daily living. Additional statements mention “second opportunity to live without joint pain”. --- Comparative Advantages over Traditional Approaches Unlike purely symptomatic treatments (NSAIDs, analgesics), Cartinew focuses on structural and regenerative support, not just pain relief. Where surgery (joint replacement) is often the last resort, Cartinew may offer a non-invasive alternative or adjunct, especially in earlier disease stages. The multiple-form presentation (capsule + topical) allows for a holistic joint health approach—internal nourishment + external support. Dr. Gómez Aguado’s status as an orthopaedic surgeon lends credibility and clinical insight into the product’s development. --- Branding, Vision & Global Outreach Dr. Gómez Aguado’s vision extends beyond one region: he is committed to globalising access to advanced joint health solutions from Latin America. His recognition by the Fundación Mara de Oro and his active role in international orthopaedic societies reflect this mission.